Top of page
Lawyers

Bruce K. Dallas

Lawyers

Filters

Xencor, Inc. Follow-On Offering
Davis Polk advised the sole book-running manager in connection with the $126.5 million public offering of common stock of Xencor, Inc. The common stock is listed on the NASDAQ Global Market…
BeiGene, Ltd. Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in the $200 million public offering by BeiGene, Ltd. of 6,250,000 American Depositary Shares, of…
Versartis Follow-On Offering
Davis Polk advised the joint book-running managers in connection with the $60 million follow-on offering of 4,898,000 shares of common stock of Versartis, Inc. at $12.25 per share. The…
OncoMed Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the sole book-running manager and representative of the several underwriters in connection with a $63.3 million SEC-registered offering of 6,325,000 shares of common…
Global Blood Therapeutics, Inc. Follow-On Offering
Davis Polk advised the joint book-running managers in connection with the $120 million follow-on offering of common stock of Global Blood Therapeutics, Inc. Global Blood’s common stock is…
TTX Company $350 Million Medium-Term Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by TTX Company of $350 million aggregate principal amount of its 4.200%…
Back to top